Trevi Therapeutics (TRVI) Short term Debt (2021 - 2023)

Trevi Therapeutics (TRVI) posted quarterly Short term Debt of $7.5 million for Q1 2023, up 6.89% year-over-year from $7.0 million in Q1 2022, and up 6.89% quarter-over-quarter from $7.0 million in Q4 2022.

Trevi Therapeutics (TRVI) Short term Debt (2021 - 2023) Analysis & Trends

Trevi Therapeutics' Short term Debt history runs 3 years deep, the most recent figure standing at $7.5 million for Q1 2023.

  • In Q1 2023, Short term Debt rose 6.89% year-over-year to $7.5 million; the TTM figure through Mar 2023 stood at $7.5 million (up 6.89% YoY), while the FY2022 annual figure was $7.0 million, up 20.01% from the prior year.
  • Short term Debt for Q1 2023 stood at $7.5 million, up from $7.0 million in the prior quarter.
  • The five-year high for Short term Debt was $7.5 million in Q1 2023, with the low at $583000.0 in Q1 2021.
  • The 3-year median for Short term Debt is $7.0 million (2022), against an average of $5.4 million.
  • The sharpest annual moves came in 2022 and 2023: Short term Debt jumped 1100.69% in 2022, then grew 6.89% in 2023.
  • Trevi Therapeutics' Short term Debt stood at $5.8 million in 2021, then advanced by 20.01% to $7.0 million in 2022, then grew by 6.89% to $7.5 million in 2023.
  • Business Quant data shows TRVI's Short term Debt at $7.5 million in Q1 2023, $7.0 million in Q4 2022, and $7.0 million in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Trevi Therapeutics 2.63 Bn 2.63 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2023 7.48 Mn
Dec 31, 2022 7.00 Mn
Sep 30, 2022 7.00 Mn
Jun 30, 2022 7.00 Mn
Mar 31, 2022 7.00 Mn
Dec 31, 2021 5.83 Mn
Sep 30, 2021 4.08 Mn
Jun 30, 2021 2.33 Mn
Mar 31, 2021 583,000.00